End Stage Renal Disease (ESRD) Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders, Others); Indication (End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, End Stage Renal Disease (ESRD)Induced Hyperphosphatemia, End Stage Renal Disease (ESRD) Induced Hyperkalaemia); Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), and geography
Report Code: TIPRE00016858 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 End Stage Renal Disease (ESRD) Drug Market - By Product Type
1.3.2 End Stage Renal Disease (ESRD) Drug Market - By Indication
1.3.3 End Stage Renal Disease (ESRD) Drug Market - By Distribution Channel
1.3.4 End Stage Renal Disease (ESRD) Drug Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. END STAGE RENAL DISEASE (ESRD) DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. END STAGE RENAL DISEASE (ESRD) DRUG - GLOBAL MARKET OVERVIEW
6.2. END STAGE RENAL DISEASE (ESRD) DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. CALCIMIMETICS
7.3.1. Overview
7.3.2. Calcimimetics Market Forecast and Analysis
7.4. VITAMIN D
7.4.1. Overview
7.4.2. Vitamin D Market Forecast and Analysis
7.5. STEROLS
7.5.1. Overview
7.5.2. Sterols Market Forecast and Analysis
7.6. POTASSIUM BINDERS
7.6.1. Overview
7.6.2. Potassium Binders Market Forecast and Analysis
7.7. CALCIUM-BASED PHOSPHATE BINDERS
7.7.1. Overview
7.7.2. Calcium-Based Phosphate Binders Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. END STAGE RENAL DISEASE (ESRD) INDUCED HYPERPARATHYROIDISM
8.3.1. Overview
8.3.2. End Stage Renal Disease (ESRD) Induced Hyperparathyroidism Market Forecast and Analysis
8.4. END STAGE RENAL DISEASE (ESRD)INDUCED HYPERPHOSPHATEMIA
8.4.1. Overview
8.4.2. End Stage Renal Disease (ESRD)Induced Hyperphosphatemia Market Forecast and Analysis
8.5. END STAGE RENAL DISEASE (ESRD) INDUCED HYPERKALAEMIA
8.5.1. Overview
8.5.2. End Stage Renal Disease (ESRD) Induced Hyperkalaemia Market Forecast and Analysis
9. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
9.5. RETAIL PHARMACIES
9.5.1. Overview
9.5.2. Retail Pharmacies Market Forecast and Analysis
10. END STAGE RENAL DISEASE (ESRD) DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America End Stage Renal Disease (ESRD) Drug Market Overview
10.1.2 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.1.3 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.1.4 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.1.5 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.1.6.1 United States End Stage Renal Disease (ESRD) Drug Market
10.1.6.1.1 United States End Stage Renal Disease (ESRD) Drug Market by Product Type
10.1.6.1.2 United States End Stage Renal Disease (ESRD) Drug Market by Indication
10.1.6.1.3 United States End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.1.6.2 Canada End Stage Renal Disease (ESRD) Drug Market
10.1.6.2.1 Canada End Stage Renal Disease (ESRD) Drug Market by Product Type
10.1.6.2.2 Canada End Stage Renal Disease (ESRD) Drug Market by Indication
10.1.6.2.3 Canada End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.1.6.3 Mexico End Stage Renal Disease (ESRD) Drug Market
10.1.6.3.1 Mexico End Stage Renal Disease (ESRD) Drug Market by Product Type
10.1.6.3.2 Mexico End Stage Renal Disease (ESRD) Drug Market by Indication
10.1.6.3.3 Mexico End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe End Stage Renal Disease (ESRD) Drug Market Overview
10.2.2 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.2.3 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.2.4 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.2.5 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.2.6.1 Germany End Stage Renal Disease (ESRD) Drug Market
10.2.6.1.1 Germany End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.1.2 Germany End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.1.3 Germany End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.2 France End Stage Renal Disease (ESRD) Drug Market
10.2.6.2.1 France End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.2.2 France End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.2.3 France End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.3 Italy End Stage Renal Disease (ESRD) Drug Market
10.2.6.3.1 Italy End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.3.2 Italy End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.3.3 Italy End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.4 Spain End Stage Renal Disease (ESRD) Drug Market
10.2.6.4.1 Spain End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.4.2 Spain End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.4.3 Spain End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.5 United Kingdom End Stage Renal Disease (ESRD) Drug Market
10.2.6.5.1 United Kingdom End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.5.2 United Kingdom End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.5.3 United Kingdom End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.6 Rest of Europe End Stage Renal Disease (ESRD) Drug Market
10.2.6.6.1 Rest of Europe End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.6.2 Rest of Europe End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.6.3 Rest of Europe End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Overview
10.3.2 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.3.3 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.3.6.1 Australia End Stage Renal Disease (ESRD) Drug Market
10.3.6.1.1 Australia End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.1.2 Australia End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.1.3 Australia End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.2 China End Stage Renal Disease (ESRD) Drug Market
10.3.6.2.1 China End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.2.2 China End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.2.3 China End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.3 India End Stage Renal Disease (ESRD) Drug Market
10.3.6.3.1 India End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.3.2 India End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.3.3 India End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.4 Japan End Stage Renal Disease (ESRD) Drug Market
10.3.6.4.1 Japan End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.4.2 Japan End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.4.3 Japan End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.5 South Korea End Stage Renal Disease (ESRD) Drug Market
10.3.6.5.1 South Korea End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.5.2 South Korea End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.5.3 South Korea End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.6 Indonesia End Stage Renal Disease (ESRD) Drug Market
10.3.6.6.1 Indonesia End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.6.2 Indonesia End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.6.3 Indonesia End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.7 Rest of Asia-Pacific End Stage Renal Disease (ESRD) Drug Market
10.3.6.7.1 Rest of Asia-Pacific End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.7.2 Rest of Asia-Pacific End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.7.3 Rest of Asia-Pacific End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Overview
10.4.2 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.4.3 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa End Stage Renal Disease (ESRD) Drug Market
10.4.6.1.1 South Africa End Stage Renal Disease (ESRD) Drug Market by Product Type
10.4.6.1.2 South Africa End Stage Renal Disease (ESRD) Drug Market by Indication
10.4.6.1.3 South Africa End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.4.6.2 Saudi Arabia End Stage Renal Disease (ESRD) Drug Market
10.4.6.2.1 Saudi Arabia End Stage Renal Disease (ESRD) Drug Market by Product Type
10.4.6.2.2 Saudi Arabia End Stage Renal Disease (ESRD) Drug Market by Indication
10.4.6.2.3 Saudi Arabia End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.4.6.3 U.A.E End Stage Renal Disease (ESRD) Drug Market
10.4.6.3.1 U.A.E End Stage Renal Disease (ESRD) Drug Market by Product Type
10.4.6.3.2 U.A.E End Stage Renal Disease (ESRD) Drug Market by Indication
10.4.6.3.3 U.A.E End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa End Stage Renal Disease (ESRD) Drug Market
10.4.6.4.1 Rest of Middle East and Africa End Stage Renal Disease (ESRD) Drug Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa End Stage Renal Disease (ESRD) Drug Market by Indication
10.4.6.4.3 Rest of Middle East and Africa End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America End Stage Renal Disease (ESRD) Drug Market Overview
10.5.2 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.5.3 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.5.5 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil End Stage Renal Disease (ESRD) Drug Market
10.5.6.1.1 Brazil End Stage Renal Disease (ESRD) Drug Market by Product Type
10.5.6.1.2 Brazil End Stage Renal Disease (ESRD) Drug Market by Indication
10.5.6.1.3 Brazil End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.5.6.2 Argentina End Stage Renal Disease (ESRD) Drug Market
10.5.6.2.1 Argentina End Stage Renal Disease (ESRD) Drug Market by Product Type
10.5.6.2.2 Argentina End Stage Renal Disease (ESRD) Drug Market by Indication
10.5.6.2.3 Argentina End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.5.6.3 Rest of South and Central America End Stage Renal Disease (ESRD) Drug Market
10.5.6.3.1 Rest of South and Central America End Stage Renal Disease (ESRD) Drug Market by Product Type
10.5.6.3.2 Rest of South and Central America End Stage Renal Disease (ESRD) Drug Market by Indication
10.5.6.3.3 Rest of South and Central America End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL END STAGE RENAL DISEASE (ESRD) DRUG MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. END STAGE RENAL DISEASE (ESRD) DRUG MARKET, KEY COMPANY PROFILES
13.1. ABBVIE INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AMGEN
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ASTRAZENECA
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SANOFI
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. KYOWA KIRIN CO., LTD.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. TAKEDA PHARMACEUTICAL COMPANY LIMITED
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ASTELLAS PHARMA INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BAYER AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. VIFOR PHARMA MANAGEMENT LTD.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. AKEBIA DRUGS, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 End Stage Renal Disease (ESRD) Drug Market - By Product Type
1.3.2 End Stage Renal Disease (ESRD) Drug Market - By Indication
1.3.3 End Stage Renal Disease (ESRD) Drug Market - By Distribution Channel
1.3.4 End Stage Renal Disease (ESRD) Drug Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. END STAGE RENAL DISEASE (ESRD) DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. END STAGE RENAL DISEASE (ESRD) DRUG - GLOBAL MARKET OVERVIEW
6.2. END STAGE RENAL DISEASE (ESRD) DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. CALCIMIMETICS
7.3.1. Overview
7.3.2. Calcimimetics Market Forecast and Analysis
7.4. VITAMIN D
7.4.1. Overview
7.4.2. Vitamin D Market Forecast and Analysis
7.5. STEROLS
7.5.1. Overview
7.5.2. Sterols Market Forecast and Analysis
7.6. POTASSIUM BINDERS
7.6.1. Overview
7.6.2. Potassium Binders Market Forecast and Analysis
7.7. CALCIUM-BASED PHOSPHATE BINDERS
7.7.1. Overview
7.7.2. Calcium-Based Phosphate Binders Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. END STAGE RENAL DISEASE (ESRD) INDUCED HYPERPARATHYROIDISM
8.3.1. Overview
8.3.2. End Stage Renal Disease (ESRD) Induced Hyperparathyroidism Market Forecast and Analysis
8.4. END STAGE RENAL DISEASE (ESRD)INDUCED HYPERPHOSPHATEMIA
8.4.1. Overview
8.4.2. End Stage Renal Disease (ESRD)Induced Hyperphosphatemia Market Forecast and Analysis
8.5. END STAGE RENAL DISEASE (ESRD) INDUCED HYPERKALAEMIA
8.5.1. Overview
8.5.2. End Stage Renal Disease (ESRD) Induced Hyperkalaemia Market Forecast and Analysis
9. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
9.5. RETAIL PHARMACIES
9.5.1. Overview
9.5.2. Retail Pharmacies Market Forecast and Analysis
10. END STAGE RENAL DISEASE (ESRD) DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America End Stage Renal Disease (ESRD) Drug Market Overview
10.1.2 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.1.3 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.1.4 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.1.5 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.1.6.1 United States End Stage Renal Disease (ESRD) Drug Market
10.1.6.1.1 United States End Stage Renal Disease (ESRD) Drug Market by Product Type
10.1.6.1.2 United States End Stage Renal Disease (ESRD) Drug Market by Indication
10.1.6.1.3 United States End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.1.6.2 Canada End Stage Renal Disease (ESRD) Drug Market
10.1.6.2.1 Canada End Stage Renal Disease (ESRD) Drug Market by Product Type
10.1.6.2.2 Canada End Stage Renal Disease (ESRD) Drug Market by Indication
10.1.6.2.3 Canada End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.1.6.3 Mexico End Stage Renal Disease (ESRD) Drug Market
10.1.6.3.1 Mexico End Stage Renal Disease (ESRD) Drug Market by Product Type
10.1.6.3.2 Mexico End Stage Renal Disease (ESRD) Drug Market by Indication
10.1.6.3.3 Mexico End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe End Stage Renal Disease (ESRD) Drug Market Overview
10.2.2 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.2.3 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.2.4 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.2.5 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.2.6.1 Germany End Stage Renal Disease (ESRD) Drug Market
10.2.6.1.1 Germany End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.1.2 Germany End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.1.3 Germany End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.2 France End Stage Renal Disease (ESRD) Drug Market
10.2.6.2.1 France End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.2.2 France End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.2.3 France End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.3 Italy End Stage Renal Disease (ESRD) Drug Market
10.2.6.3.1 Italy End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.3.2 Italy End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.3.3 Italy End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.4 Spain End Stage Renal Disease (ESRD) Drug Market
10.2.6.4.1 Spain End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.4.2 Spain End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.4.3 Spain End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.5 United Kingdom End Stage Renal Disease (ESRD) Drug Market
10.2.6.5.1 United Kingdom End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.5.2 United Kingdom End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.5.3 United Kingdom End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.6 Rest of Europe End Stage Renal Disease (ESRD) Drug Market
10.2.6.6.1 Rest of Europe End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.6.2 Rest of Europe End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.6.3 Rest of Europe End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Overview
10.3.2 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.3.3 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.3.6.1 Australia End Stage Renal Disease (ESRD) Drug Market
10.3.6.1.1 Australia End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.1.2 Australia End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.1.3 Australia End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.2 China End Stage Renal Disease (ESRD) Drug Market
10.3.6.2.1 China End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.2.2 China End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.2.3 China End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.3 India End Stage Renal Disease (ESRD) Drug Market
10.3.6.3.1 India End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.3.2 India End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.3.3 India End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.4 Japan End Stage Renal Disease (ESRD) Drug Market
10.3.6.4.1 Japan End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.4.2 Japan End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.4.3 Japan End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.5 South Korea End Stage Renal Disease (ESRD) Drug Market
10.3.6.5.1 South Korea End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.5.2 South Korea End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.5.3 South Korea End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.6 Indonesia End Stage Renal Disease (ESRD) Drug Market
10.3.6.6.1 Indonesia End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.6.2 Indonesia End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.6.3 Indonesia End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.7 Rest of Asia-Pacific End Stage Renal Disease (ESRD) Drug Market
10.3.6.7.1 Rest of Asia-Pacific End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.7.2 Rest of Asia-Pacific End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.7.3 Rest of Asia-Pacific End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Overview
10.4.2 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.4.3 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa End Stage Renal Disease (ESRD) Drug Market
10.4.6.1.1 South Africa End Stage Renal Disease (ESRD) Drug Market by Product Type
10.4.6.1.2 South Africa End Stage Renal Disease (ESRD) Drug Market by Indication
10.4.6.1.3 South Africa End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.4.6.2 Saudi Arabia End Stage Renal Disease (ESRD) Drug Market
10.4.6.2.1 Saudi Arabia End Stage Renal Disease (ESRD) Drug Market by Product Type
10.4.6.2.2 Saudi Arabia End Stage Renal Disease (ESRD) Drug Market by Indication
10.4.6.2.3 Saudi Arabia End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.4.6.3 U.A.E End Stage Renal Disease (ESRD) Drug Market
10.4.6.3.1 U.A.E End Stage Renal Disease (ESRD) Drug Market by Product Type
10.4.6.3.2 U.A.E End Stage Renal Disease (ESRD) Drug Market by Indication
10.4.6.3.3 U.A.E End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa End Stage Renal Disease (ESRD) Drug Market
10.4.6.4.1 Rest of Middle East and Africa End Stage Renal Disease (ESRD) Drug Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa End Stage Renal Disease (ESRD) Drug Market by Indication
10.4.6.4.3 Rest of Middle East and Africa End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America End Stage Renal Disease (ESRD) Drug Market Overview
10.5.2 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.5.3 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.5.5 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil End Stage Renal Disease (ESRD) Drug Market
10.5.6.1.1 Brazil End Stage Renal Disease (ESRD) Drug Market by Product Type
10.5.6.1.2 Brazil End Stage Renal Disease (ESRD) Drug Market by Indication
10.5.6.1.3 Brazil End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.5.6.2 Argentina End Stage Renal Disease (ESRD) Drug Market
10.5.6.2.1 Argentina End Stage Renal Disease (ESRD) Drug Market by Product Type
10.5.6.2.2 Argentina End Stage Renal Disease (ESRD) Drug Market by Indication
10.5.6.2.3 Argentina End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.5.6.3 Rest of South and Central America End Stage Renal Disease (ESRD) Drug Market
10.5.6.3.1 Rest of South and Central America End Stage Renal Disease (ESRD) Drug Market by Product Type
10.5.6.3.2 Rest of South and Central America End Stage Renal Disease (ESRD) Drug Market by Indication
10.5.6.3.3 Rest of South and Central America End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL END STAGE RENAL DISEASE (ESRD) DRUG MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. END STAGE RENAL DISEASE (ESRD) DRUG MARKET, KEY COMPANY PROFILES
13.1. ABBVIE INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AMGEN
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ASTRAZENECA
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SANOFI
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. KYOWA KIRIN CO., LTD.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. TAKEDA PHARMACEUTICAL COMPANY LIMITED
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ASTELLAS PHARMA INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BAYER AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. VIFOR PHARMA MANAGEMENT LTD.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. AKEBIA DRUGS, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. AbbVie Inc.
2. Amgen
3. AstraZeneca
4. Sanofi
5. Kyowa Kirin Co., Ltd.
6. Takeda Pharmaceutical Company Limited
7. Astellas Pharma Inc.
8. Bayer AG
9. Vifor Pharma Management Ltd.
10. Akebia Drugs, Inc.
1. AbbVie Inc.
2. Amgen
3. AstraZeneca
4. Sanofi
5. Kyowa Kirin Co., Ltd.
6. Takeda Pharmaceutical Company Limited
7. Astellas Pharma Inc.
8. Bayer AG
9. Vifor Pharma Management Ltd.
10. Akebia Drugs, Inc.
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount